“It came as a surprise that our approach works so well,” Lu said. In preclinical (non-human) studies, the vaccine completely ...

The five-year survival rate for this cancer is just 13.3%. "Pancreatic cancer is super aggressive," said Zheng-Rong (ZR) Lu, a biomedical engineer at the Case School of Engineering.

Pancreatic cancer has a five-year survival rate of just 13%, making it the deadliest cancer, according to the American Cancer Society. It typically causes no symptoms until it has already ...

Researchers at Case Western Reserve University and Cleveland Clinic are developing vaccines targeting pancreatic cancer that could eliminate the disease, leaving a patient cancer-free. So far, the ...

Pancreatic cancer vaccines eliminate disease in preclinical studies Pancreatic cancer has a five-year survival rate of just 13%, making it the deadliest cancer, according to the American Cancer ...

A NEW vaccine could cure up to half of all pancreatic cancer cases and may one day wipe out the disease entirely, scientists say. Pancreatic cancer is the deadliest cancer in the world. Some 10,500… ...

The researchers received a $3.27 million, five-year grant from the National Cancer Institute to further explore the therapeutic use of vaccines in preclinical models of PDAC.

Scientists conducting medical research are facing an existential crisis: Layoffs and budget cuts pushed by President Trump that, they say, jeopardize finding a cure for cancer.

Using a newly discovered byproduct of dying cancer cells, University of Wisconsin–Madison researchers are developing ...

As part of a clinical trial, the National Center for Tumor Diseases (NCT/UCC) Dresden is now offering patients with ...

Quanyin Hu, a professor in the UW-Madison School of Pharmacy, said the approach could theoretically be applied to any cancer ...